Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen

JOURNAL ARTICLE published 1 January 2007 in Clinical Cancer Research

Authors: Aman U. Buzdar | Vicente Valero | Nuhad K. Ibrahim | Deborah Francis | Kristine R. Broglio | Richard L. Theriault | Lajos Pusztai | Marjorie C. Green | Sonja E. Singletary | Kelly K. Hunt | Aysegul A. Sahin | Francisco Esteva | William F. Symmans | Michael S. Ewer | Thomas A. Buchholz | Gabriel N. Hortobagyi